Diagnostic accuracy of Tumor M2-Pyruvate Kinase (tM2-PK) as a non-invasive biomarker in colorectal cancer: A systematic review and meta-analysis

AH Aalami, A Shahriari, M Mazaheri, F Aalami… - Clinical …, 2023 - Elsevier
Introduction The tumor pyruvate kinase M2 isoform (tM2-PK) is a glycolytic enzyme isoform
that is present on the surface of rapidly proliferating cancer cells. The objective of this …

Comparison of faecal protein biomarkers' diagnostic accuracy for colorectal advanced neoplasms: a systematic review and meta-analysis

A Nasir Kansestani, ME Zare, Q Tong, J Zhang - Scientific Reports, 2022 - nature.com
Early diagnosis of colorectal advanced neoplasms (ANs), including colorectal cancer (CRC)
and advanced adenoma (AA), has a positive effect on the survival rate. As a first attempt, the …

Diagnosis biomarkers of cholangiocarcinoma in human bile: an evidence-based study

F Bao, J Liu, H Chen, L Miao, Z Xu, G Zhang - Cancers, 2022 - mdpi.com
Simple Summary A liquid biopsy has the characteristics of low trauma and easy acquisition
in the diagnosis of cholangiocarcinoma. Many researchers try to find diagnostic or …

Faecal diagnostic biomarkers for colorectal cancer

A Cruz, CM Carvalho, A Cunha, A Crespo, Á Iglesias… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer (CRC) is a significant public health problem, being a
major cause of cancer death worldwide. Hence, the identification of biomarkers able to …

Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer

H Jiang, S Zhou, G Li - Frontiers in pharmacology, 2023 - frontiersin.org
Colorectal cancer (CRC) is the third most common and second most lethal type of cancer
worldwide, presenting major health risks as well as economic costs to both people and …

The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing Colonoscopy

M Khosravi, AA Anoushirvani, Z Kheiri… - … in Cancer Research …, 2023 - journals.sagepub.com
Despite the use of colonoscopy to detect colon cancer due to its aggressiveness, high cost,
and lack of patient compliance, the use of laboratory tests with high accuracy and sensitivity …

Early Detection of Colorectal Cancer: Conventional Techniques and Current Biomarkers

S Ahmadpour, MA Habibi, MR Pashaei… - Current Cancer …, 2024 - benthamdirect.com
Colorectal cancer (CRC) is the third most common cancer worldwide, and the incidence of
CRC seems to increase gradually. The survival of CRC varies in different countries …

Where do we stand with screening for colorectal cancer and advanced adenoma based on serum protein biomarkers? A systematic review

A Grancher, S Cuissy, H Girot, A Gillibert… - Molecular … - Wiley Online Library
Colorectal cancer (CRC) screening has been proven to reduce both mortality and the
incidence of this disease. Most CRC screening programs are based on fecal …

Proteomic Analysis of Tumor-specific Biomarkers in Colon Cancer

YA Chien, HC Chou, CC Yang, YS Wang… - Current …, 2022 - ingentaconnect.com
Background: With the development of medicine and technological advancement, the
concept of precision medicine is becoming popular, and the traditional principle of all-in-one …

[PDF][PDF] The Importance of Evaluating Serum Levels of Tumor Markers M2-PK and Inhibin A in Patients Undergoing Colonoscopy

MD Zahedin Kheiri, MD Ali Rahbari - 2023 - researchgate.net
Despite the use of colonoscopy to detect colon cancer due to its aggressiveness, high cost,
and lack of patient compliance, the use of laboratory tests with high accuracy and sensitivity …